Navigation Links
Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013
Date:4/25/2013

efects, risks related to the introduction of new instruments manufactured by third parties, risks associated with competing in the human diagnostic market, risks related to transitioning our medical sales to Abbott, risks related to the protection of Abaxis' intellectual property or claims of infringement of intellectual property asserted by third parties and risks related to condition of the United States economy.  Readers should also refer to the section entitled "Risk Factors" in Abaxis' Annual Report on Form 10-K, its most recent Quarterly Report on Form 10-Q and Abaxis' other periodic reports filed with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

Financial Tables to FollowABAXIS, INC.Condensed Consolidated Statements of Income(In thousands, except per share data)(Unaudited)Three Months EndedTwelve Months EndedMarch 31,March 31,2013201220132012Revenues

$
49,951

$
42,718

$
86,025

$
56,596Cost of revenues

23,768

19,337

87,794

71,493Gross profit

26,183

23,381

98,231

85,103Operating expenses:Research and development 

3,229

3,150

13,577

12,246Sales and marketing 

11,296

11,204

46,943

39,618General and administrative

2,672

2,588

12,825

13,782Gain from legal settlement

-

-

(17,250)

-Total operating expenses

17,197

16,942

56,095

65,646Income from operations

8,986

6,439

42,136

19,457Interest and other income (expense), net

(65)

451

253

710Income before income tax provision<
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
2. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
3. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
4. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
5. Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013
6. Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013
7. Abaxis Declares Special Cash Dividend of $1.00 Per Share
8. Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
9. Abaxis, Inc. to Participate in Sidoti & Companys Inaugural One-on-One Conference
10. Abaxis, Inc. to Present at the Stephens Fall Investment Conference
11. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... REDMOND, Washington , 29. Juli 2015 ... deutschen Diabeteszentrums wurde festgestellt, dass die tägliche ... von Nutraceutix die menschliche Darmflora anreichert und ... Insulinsekretion erhöhen. Die Studie umfasste die tägliche ... (ATCC-Stamm SD-5865) in Tablettenform unter Verwendung der ...
(Date:7/29/2015)... 29, 2015 Touro College has announced that it ... for one of five media marijuana licenses to be issued ... of Health (DOH).  If CanniCare is selected, ... "Our college is supportive of medicinal development ... the Touro College System. "There is still a great deal ...
(Date:7/29/2015)... , July 29, 2015  AcelRx Pharmaceuticals, ... company focused on the development and commercialization of ... breakthrough pain, today announced that it will release ... Monday, Aug 3rd, 2015. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on Aug 3rd, ...
Breaking Medicine Technology:Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2Touro College Announces Support for CanniCare's Medical Cannabis License Application 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4
... at TCT 2007; EVEREST II Study ... Enrollment Continues, ... a successful result with the percutaneous MitraClip device did not need,mitral ... improved function of the left ventricle (commonly known,as reverse remodeling), according ...
... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Administration (FDA) has accepted for filing the,Company,s supplemental ... (tigecycline) for the treatment of patients with,community-acquired pneumonia ... of,the application. The FDA may approve or disapprove ...
Cached Medicine Technology:New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 2New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 3New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 4New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 5FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 2FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 3FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 4FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 5FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 6
(Date:7/29/2015)... ... July 29, 2015 , ... More than 28,000 students in ... children living with autism will converge upon Penn State to share the latest ... National Autism Conference will be held Aug. 3-6 at the Penn Stater Conference ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... for a five-year period, expiring November 30, 2019, during its recent meeting. , ... an application demonstrating the program’s compliance with the NCCA’s Standards for the Accreditation ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald ... alcohol addiction and mental health disorders. Acu-detox may begin taking off in the South ... drug and alcohol addiction. Although acupuncture is not a new practice, it is not ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of Burlington ... Cuff System, a new implant to treat a common source of shoulder pain and ... of additional tendon tissue, which could allow for faster healing and a decreased chance ...
(Date:7/29/2015)... ... July 29, 2015 , ... We are privileged to announce that U.S. News & World ... ninth best ophthalmology hospital in the nation for 2015-2016. This marks the 21st consecutive year ... , “It is an honor to be included in the top 10 ophthalmology hospitals ...
Breaking Medicine News(10 mins):Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3
... technique -- intrauterine insemination with controlled ovarian hyperstimulation – is ... way, for some couples. ,The results of the ... ,The research was conducted on 253 couples with unexplained infertility ... were cases where no obvious abnormalities were found. ...
... develop multiple sclerosis (MS) in comparison to non-diabetic people, ... and MS are auto-immune diseases, where the body builds ... cells in patients with diabetes, and the myelin sheath ... , Dr. Nete M. Nielsen, from the Statens ...
... chemical used to thicken everything from baby food to ... cervical cancer// and genital warts. ,Researchers found ... attaching to cells in laboratory tests. Certain strains of ... ,In the study conducted by researchers from the ...
... CPMT-06 arrived at the counseling centre on GSVM Medical ... access counseling process online// and perhaps this has meant ... available on the website www.upcpmt.nic.in. But students were dissatisfied ... after many attempts they were unable to find the ...
... in Bhopal and two of its doctors have been asked ... fine for alleged// post-operative negligence resulting in the death of ... to Ayushman Hospital following swelling in her uterus and respiratory ... uterus. Since the tumor was not malignant and the possibility ...
... pockets of the North Eastern region have the highest cancer ... country, a study done by the National Cancer Registry Programme ... maximum number of tongue cancer surpassing the figure of Bhopal ... ago, Dr A Nandkumar, NCRP officer in-charge told a medical ...
Cached Medicine News:Health News:Common Chemical From Seaweed Could Help In The Fight Against Cervical Cancer Virus-HPV 2
... balloon. ,The first outside-the-balloon, dual-wire dilatation catheter. ... represents an innovative new approach to dilatation. ... the two wires to create expansion planes ... challenging lesions. ,The FX miniRAIL RX PTCA ...
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
... Millar Mikro-Tip pressure intravascular catheters ... accurate method of measuring pressures in ... reusable, thromboresistant Mikro-Tip catheters are ideal ... catheters range in size from 2 ...
... pressure sensor catheters incorporate a ... injection/guide wire, or high-speed injection/guide ... high-speed injection has two laterally ... an open-end pigtail extension for ...
Medicine Products: